Three years after the establishment of Nkosi'€™s Haven in Berea, Johannesburg, and one year after the death of the celebrated young AIDS activist Nkosi Johnson, a new home for HIV positive mothers and their children has been opened in Berea, in honour of the late Nkosi.

Despite delays caused by protocol, preparations for the AIDS vaccine trials in South Africa are still underway and clinical researchers and scientists are hopeful that the Phase One tests will start early next year. This sense of optimism follows months of discussion and debate amongst the Medicines Control Council, the government as well as the vaccines'€™ developers. It is hoped that the extensive consultations will help accelerate the onset of the vaccines trials '€“ the search for the ultimate hope in HIV prevention. Khopotso Bodibe went out to seek clarity on the outstanding issues.

The question that AIDS activists have been asking is: Are the vaccines that will be tested in South Africa specific to sub-type C, the virus that is predominantly circulating in the country and the southern African sub-region? Khopotso Bodibe put that question to Dr Eftyhia Vardas, Director of the HIV/AIDS Vaccine Division at the Peri-natal HIV Reseacrh Unit at Chris Hani Baragwanath Hospital, in Soweto.